ASSIST Digital Application for Cancer Symptom Management
This study is testing a smartphone app called ASSIST, which uses artificial intelligence (AI) to help manage symptoms during cancer treatment. It's for people with breast cancer, lymphoma, or colorectal cancer who are starting or have recently started systemic treatment (like chemotherapy). Researchers want to see if the ASSIST app is easy to use and if patients like it. You would use the ASSIST app for 12 weeks and complete surveys. The study will compare patients using the app to those receiving standard care from their oncology team. The goal is to enroll 60 participants.
- Study design
- This interventional study plans to enroll 60 participants. It will compare the ASSIST phone application to usual clinical care.
- What's involved
- You would use the ASSIST phone application for 12 weeks and complete surveys. You will also receive standard care from your oncology team.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoints are measured from enrollment to the end of the intervention at 12 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Remote Monitoring and Symptom Management Digital Application
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Recruitment RatesFrom enrollment to end of intervention at 12 weeks
We will deem the intervention feasible if recruitment rates achieve ≥ 60% of eligible patients
- Percentage of participants using the digital application once per week in at least 7/12 weeksFrom enrollment to end of intervention at 12 weeks
The intervention will be feasible if among those enrolled and randomized to the intervention arm, ≥ 60% use ASSIST once per week in at least 7/12 weeks.